ABSTRACT TOR protein kinases are key regulators of cell growth in eukaryotes. TOR is also known as the target protein for the immunosuppressive and potentially anticancer drug rapamycin. The fission yeast Schizosaccharomyces pombe has two TOR homologs. tor1 ϩ is required under starvation and a variety of stresses, while tor2 ϩ is an essential gene. Surprisingly, to date no rapamycin-sensitive TOR-dependent function has been identified in S. pombe. Herein, we show that S. pombe auxotrophs, in particular leucine auxotrophs, are sensitive to rapamycin. This sensitivity is suppressed by deletion of the S. pombe FKBP12 or by introducing a rapamycin-binding defective tor1 allele, suggesting that rapamycin inhibits a tor1p-dependent function. Sensitivity of leucine auxotrophs to rapamycin is observed when ammonia is used as the nitrogen source and can be suppressed by its replacement with proline. Consistently, using radioactive labeled leucine, we show that cells treated with rapamycin or disrupted for tor1 ϩ are defective in leucine uptake when the nitrogen source is ammonia but not proline. Recently, it has been reported that tsc1 ϩ and tsc2 ϩ , the S. pombe homologs for the mammalian TSC1 and TSC2, are also defective in leucine uptake. TSC1 and TSC2 may antagonize TOR signaling in mammalian cells and Drosophila. We show that reduction of leucine uptake in tor1 mutants is correlated with decreased expression of three putative amino acid permeases that are also downregulated in tsc1 or tsc2. These findings suggest a possible mechanism for regulation of leucine uptake by tor1p and indicate that tor1p, as well as tsc1p and tsc2p, positively regulates leucine uptake in S. pombe. inhibits TOR kinases when in complex with FKBP12, a PI-3 and PI-4 kinases and are therefore referred to as PI3K-ubiquitous 12-kD prolyl-isomerase. The inhibition of related kinases. Accumulation of data in yeast, Drosophila, TOR by FKBP12-rapamycin complexes accounts for the and mammalian cells suggests that TOR is a central inhibition of many growth-related functions that are regulator of cellular growth. TOR controls growth in TOR dependent. Nevertheless, rapamycin also affects response to changes in the environment, particularly cellular processes through direct inhibition of the cellunutrient availability and cellular energetic status. et al. (1996) strates that rapamycin does not inhibit all TOR kinase- 1996) vation. tor1 ϩ is also required for growth at extreme tem- 
inhibits TOR kinases when in complex with FKBP12, a PI-3 and PI-4 kinases and are therefore referred to as PI3K-ubiquitous 12-kD prolyl-isomerase. The inhibition of related kinases. Accumulation of data in yeast, Drosophila, TOR by FKBP12-rapamycin complexes accounts for the and mammalian cells suggests that TOR is a central inhibition of many growth-related functions that are regulator of cellular growth. TOR controls growth in TOR dependent. Nevertheless, rapamycin also affects response to changes in the environment, particularly cellular processes through direct inhibition of the cellunutrient availability and cellular energetic status. Cell lar function of FKBP12. For example, rapamycin inhibits growth is regulated by TOR on many levels, including the function of FKBP12 in regulating the ryanodine receptranslation, ribosome biogenesis, transcription, nutrient tor Ca 2ϩ release channel in mammalian cells (Brillantes permease expression, protein degradation, and autophet al. 1994; Lehnart et al. 2003) . Rapamycin also inhibits agy (reviewed in Jacinto and Hall 2003; Fingar and several FKBP12-dependent functions in Saccharomyces Blenis 2004; Tokunaga et al. 2004) .
cerevisiae such as regulation of aspartokinase activity Rapamycin, a natural product of the soil bacterium (Alarcon and Heitman 1997) . In Schizosaccharomyces Streptomyces hygroscopicus, inhibits cellular growth and pombe, rapamycin inhibits the function of FKBP12 in proliferation of certain cell types and hence is considsexual development, leading to a decrease in mating ered a potent immunosuppressive and anticancer drug efficiency ).
(Bjornsti and Houghton 2004). Rapamycin and its
The rapamycin-FKBP12 complex binds the FRB analogs are already in medical use to prevent graft rejec-(F KBP12-rapamycin binding) domain in TOR, which tion in transplant patients and to inhibit the restenosis lies adjacent to the kinase domain. Although FKBP12-that occurs after angioplasty. In addition, rapamycin is rapamycin inhibits the kinase activity of TOR in vitro, it in clinical trials as an anticancer treatment against a does not completely inhibit TOR kinase activity in vivo (Peterson et al. 2000) . Consistently, rapamycin does not inhibit the S. cerevisiae Tor2p kinase-dependent 1 TABLE 1 TOR-dependent functions is consistent with the presence of two TOR complexes in S. cerevisiae, which differ
S. pombe strains used in this study
in their ability to bind rapamycin (Loewith et al. 2002 Stettler et al. (1996) strates that rapamycin does not inhibit all TOR kinaseleu1-32 ura4-D18 h ϩ dependent functions (Edinger et al. 2003 ). 1996) vation. tor1 ϩ is also required for growth at extreme tem- rapamycin, we previously suggested that rapamycin directly inhibits fkh1p activity in sexual development was prepared as described in Moreno et al. (1991) . YES was . This suggestion is supported by yeast extract supplemented with 75 g/ml adenine and uracil.
our ability to isolate fkh1 mutants that carry mutations EMM (Edinburgh minimal medium) was slightly modified, as at the predicted rapamycin-binding domain and confer described in Stettler et al. (1996) . Minimal medium was dominant resistance to the effect of rapamycin on the supplemented as required. Leucine, histidine, adenine, and uracil were supplemented at the concentrations of 75 g/ml, sexual development pathway . The unless otherwise indicated. For proline plates (EMM-Pro), mechanism(s) that renders S. pombe resistant to rapaammonium chloride of the EMM medium was replaced with mycin during the growth phase remains unclear. More-10 mm proline (Young and Fantes 1987) . EMM-N medium over, to date, no TOR-related function in S. pombe has contains no nitrogen. Rapamycin was used as described prebeen shown to be sensitive to inhibition by rapamycin.
viously (Weisman et al. 1997) . Normally, we use rapamycin at a final concentration of 100 ng/ml. Using higher concentraHere, we show that the rapamycin-FKBP12 complex tions (up to 250 ng/ml) did not result in more severe effects.
binds tor1p and identify amino acid uptake as a novel
Transformation of S. pombe cells was performed by electroporator1p-modulated function that is sensitive to rapamycintion (Prentice 1992). Assays for mating efficiency were car-FKBP12 inhibition. Additionally, we show that three ried out as described in Weisman et al. (1997) . Full-length tor1 plasmid constructs and site-directed mutaputative amino acid permeases are downregulated in genesis: tor1 ϩ or S1834R, S1834E, or S1834A tor1 mutations cells that lack tor1p, suggesting a possible mechanism were expressed under the regulation of the tor1 ϩ promoter for the decrease in amino acid uptake in ⌬tor1 cells.
from the LEU1-based plasmid pIRT2 (Booher and Beach 1986) or as NH 2 -terminal HA-tagged proteins from the nmt1 promoter in ura4 ϩ -based pSLF273 (Forsburg and Sherman 1997) . Mutations at the conserved serine in the tor1p, S1834E MATERIALS AND METHODS or S1834A, were created by site-directed mutagenesis using Yeast strains, media, and general techniques: Yeast strains PCR overlap extension, as described previously . Briefly, pIRT2-tor1 ϩ served as a template in a used in this article are described in Table 1 . Growth media tor1 ϩ Regulates Leucine Uptake in S. pombe PCR reaction using one primer that contained the desired study the mechanism(s) that render S. pombe resistant to mutation and another primer 220 bp downstream from the rapamycin during growth, we executed a genetic screen site of the mutation. The resulting PCR product was gel puridesigned to isolate rapamycin-sensitive mutants. During fied and used as a primer for a second round of PCR with this screen it became apparent that the growth of the primer complementary to sequences 1300 bp upstream of the site of the mutation. The resulting 1580-bp PCR product was auxotrophic strain cleaved with BglII and Bsu36I, restriction sites that reside near was partially sensitive to rapamycin, while the isogenic the fragment ends. This fragment was used to replace the prototrophic strain was completely resistant to rapacorresponding fragment in pIRT2-tor1 auxotrophs is less sensitive to rapamycin. Growth of to create the fusion protein GAL4(BD)-tor1p(FRB). Similarly, adenine auxotrophs is not inhibited by rapamycin unpIRT2 plasmids carrying tor1 mutations S1834R, S1834E, or der these conditions ( Figure 1B ). Thus, rapamycin dif-S1834A were used as templates for PCR amplification and ferentially affects growth of auxotrophic strains, leucine cloning into pGBT9. GAL4(AD)-fkh1p fusion proteins were created by PCR amplification of the ORF of fkh1 ϩ using primauxotrophy resulting in the strongest effect. 
Rapamycin sensitivity of leucine auxotrophs is res-
Measurement of leucine uptake: The method described in cued by a tor1 allele defective in rapamycin binding: If Karagiannis et al. (1999) was followed with slight modifications adopted from Cohen et al. (2003) . rapamycin sensitivity in auxotrophs is the result of TOR or ⌬tor1 cells (TA390) were grown to log phase in minimal inhibition by FKBP12-rapamcin, it is expected that mumedium. Wild-type cells were grown either in the absence or tations in tor1p that fail to bind FKBP12-rapamycin in the presence of 0.1 g/ml rapamycin. A total of 0.5 ml of would confer rapamycin resistance. The domain responlogarithmic cells (total of ‫4ف‬ ϫ 10 6 cells) grown in minimal sible for FKBP12-rapamycin binding, the FRB domain, media were harvested and resuspended in 0.5 ml minimal media containing 0.01 or 2 mm leucine together with acting with fkh1p and that this interaction occurs only observed in S1834E mutants is moderate compared to that in S1834R mutants ( Figure 2D ). In addition, while in the presence of rapamycin (Figure 2A ). Mutations into arginine (S1834R) or glutamic acid (S1834E) dra-S1834R could not fully complement the growth defects of ⌬tor1 cells under osmotic stress conditions (Weisman matically reduced FKBP12-rapamycin binding, while substitution of the conserved serine in tor1p into alaand Choder 2001), S1834E was indistinguishable from wild type in this respect (data not shown). Interestingly, nine (S1834A) exhibited an even higher binding activity compared to wild type ( Figure 2B ). Binding activities the S1834A mutation did not impair tor1p function, as it fully complemented the sexual development defect are normalized to the protein levels of the GAL4(BD)-tor1p(FRB) fusion proteins ( Figure 2C ). Thus, as has in ⌬tor1 mutants ( Figure 2D ) or the growth defect under stress conditions (data not shown). Interestingly, our data been demonstrated for other eukaryotes, the FRB domain of tor1 binds FKBP12-rapamycin, and mutating are reminiscent of data found for mTOR rapamycin-binding defective alleles. Mutating S2035 in mTOR into bulky the conserved serine within the FRB domain into a bulky amino acid disrupts rapamycin-FKBP12 binding.
amino acids caused defects in kinase activity; the extent of the defect depended on the specific substitution, Previously, we reported that the S1834R mutation is deleterious for tor1p function, although it did not affect while mutating S2035 into alanine resulted in an allele indistinguishable from wild-type mTOR (McMahon et the level of protein expression . Therefore, we tested the functionality of tor1 al. 2002) .
Having shown that S1834 is critical for rapamycin bindalleles carrying the S1834E or S1834A mutations. We transformed the mutated alleles of tor1 into ⌬tor1 cells ing in S. pombe tor1p, and bearing in mind the effects of mutating this residue on the protein function, we examand examined their ability to complement the sterility and growth defects associated with deletion of tor1 ϩ . We ined the ability of tor1 mutations to rescue rapamycinmediated growth inhibition. Significantly, S1834E, but found that S1834E could not fully complement tor1p function in sexual development; however, the defect not S1834A, rescued leucine auxotrophs from the inhib-tor1 ϩ Regulates Leucine Uptake in S. pombe Figure 2 .-tor1 mutants defective in rapamycin binding rescue the growth defect of leucine auxotrophs in the presence of rapamycin. (A) Fusion GAL4(AD)-fkh1p and GAL4(BD)-tor1p(FRB) proteins were constructed and expressed in the two-hybrid rapamycin-resistant S. cerevisiae strain (SYM4; Lorenz and Heitman 1995). Cells coexpressing both fusion proteins or only the GAL4(BD)-tor1p(FRB) fusion protein were spotted onto plates containing X-gal in the absence or the presence of 0.1 g/ml rapamycin. (B) Fusion GAL4 (BD)-tor1(FRB) proteins carrying specific mutations at S1834 were coexpressed with GAL4(AD)-fkh1p in SYM4 in medium containing 0.1 g/ml rapamycin (WT, wild type; SE, S1834E; SR, S1834R; SA, S1834A). ␤-Galactosidase activity measured by the liquid test is normalized to the amount of the fusion protein as assessed by Western blot analysis in B. (C) GAL4(BD)-tor1p(FRB) proteins expressed in SYM4 were detected by Western blot analysis using ␣-GAL4 antibodies. (D) Mating efficiency of the ⌬tor1 h 90 strain (TA157) transformed with plasmid carrying no insert, tor1 ϩ , or tor1 mutations in the FRB domain. Mating efficiency (%) was determined following 3 days incubation at 30Њ in either EMM-N or EMM. Mating efficiency typical for wild-type cells is in boldface type. (E) ⌬tor1 leu1-32 (TA353) transformed with pSLF273 (ura4 ϩ -based plasmids) carrying tor1 ϩ , S1834E, or S1834A mutants was streaked onto minimal plates with no rapamycin (ϪR) or with 0.1 g/ml rapamycin (ϩR). Only cells transformed with the S1834E allele could grow in the presence of rapamycin.
itory effect of rapamycin ( Figure 2E ). S1834R did not of leucine from 75 to 500 g/ml partially suppressed rapamycin sensitivity, supporting our hypothesis that suppress rapamycin sensitivity, most likely due to deleterious effects of this mutation on the protein function rapamycin inhibits leucine uptake from the environment ( Figure 3A) . (data not shown). Taken together, our data showing that only a rapamycin-binding defective allele rescues leucine Amino acid permeases in S. cerevisiae are divided into two classes, according to their regulation and function auxotrophs from inhibition by rapamycin suggest that rapamycin inhibits a tor1p-dependent function.
(Sophianopoulou and Diallinas 1995). One class is derepressed under poor nitrogen conditions and is beRapamycin growth inhibition of leucine auxotrophs is suppressed by excess of leucine or by replacing the lieved to transport amino acids for nitrogen source. The other class is expressed under good nitrogen conditions nitrogen source in the medium: The inability of leucine auxotrophs to grow on minimal medium in the presence and regulates the uptake of specific amino acids for the use of protein synthesis. Less is known about the of rapamycin suggests a defect in leucine uptake. To test this possibility, we examined the growth of leucine function and regulation of amino acid permeases in S. pombe. However, amino acid import as the function of auxotrophs on rapamycin-containing plates in the presence of excess leucine. An increase of the concentration the nitrogen source has been reported during the study , and double-mutant (⌬fkh1 leu1-32 h Ϫ ) strains were streaked onto plates containing 5 g/liter NH 4 Cl, 1 g/liter NH 4 Cl, or 10 mm proline with or without rapamycin. Plates were incubated at 30Њ for 3 days before being photographed. of high pH sensitivity (Karagiannis et al. 1999) . The MAPK cascade is involved in amino acid uptake (Karagiannis et al. 1999 ). Accordingly, ⌬wis1 or ⌬spc1 mugrowth of leucine auxotrophs is sensitive to high pH in the presence of ammonia, whereas deletion of the E3 tants suppressed the growth inhibition of leucine auxotrophs when placed in the genetic background of a ubiquitin ligase pub1 ϩ , the S. pombe homolog of the nitrogen permease inactivator NPI1/RSP5, abolishes pH partially active pub1 mutant (Karagiannis et al. 1999) . If rapamycin inhibits leucine uptake, then it might be sensitivity (Karagiannis et al. 1999) . Similarly, we have found that the inhibitory effect of rapamycin on leucine expected that mutations in the spc1p MAPK cascade may also suppress sensitivity to rapamycin. Indeed, loss auxotrophs is dependent on the presence of ammonia. Thus, when proline is used as the nitrogen source or of function of either wis1 ϩ or spc1 ϩ suppressed sensitivity of leucine auxotrophs to rapamycin (Figure 4) , supportwhen the ammonia concentration is decreased, rapamycin does not inhibit growth of leucine auxotrophs ing our suggestion that the effect of rapamycin involves a defect in leucine uptake. Interestingly, deletion of ( Figure 3B ). These data suggest that rapamycin inhibits the growth of leucine auxotrophs due to insufficient atf1 ϩ , which encodes a transcription factor that is activated by spc1p (Shiozaki and Russell 1996; Wilkinleucine uptake in a mechanism that involves amino acid permeases regulated by ammonia.
son et al. 1996) did not suppress rapamycin sensitivity (Figure 4 ). This finding suggests that in respect to reguRapamycin sensitivity of leucine auxotrophs is suppressed by mutations in the stress-activated MAPK caslation of leucine uptake, the wis1p-spc1p cascade functions through an atf1p-independent mechanism. The cade: Studies of the sensitivity of leucine auxotrophs to high pH in S. pombe suggested that stress-activated spc1p mechanism by which mutations in components of the tor1 ϩ Regulates Leucine Uptake in S. pombe Figure 4 .-Mutations in the MAPK-signaling cascade suppress rapamycin sensitivity of leucine auxotrophs. S. pombe strains leu1-32 h Ϫ , ⌬wis1 leu1-32, ⌬spc1 leu1-32, and ⌬atf1 leu1-32 were streaked onto minimal plates with or without rapamycin. Plates were incubated at 30Њ for 3 days before being photographed.
MAPK cascade suppress leucine uptake defect is not yet amino acid permeases 7G5.06, isp5, and c869.10 show high sequence similarity to the general amino acid perknown.
Leucine uptake is inhibited in ⌬tor1 or rapamycinmease, GAP1, in S. cerevisiae (van Slegtenhorst et al. treated cells: To directly test the hypothesis that rapamycin inhibits leucine uptake by blocking a tor1p-dependent function, we used 3 H-labeled leucine to measure leucine uptake of ⌬tor1 cells and wild-type cells treated with rapamycin. Two leucine-uptake systems were identified in S. pombe, a high-and a low-affinity system (Sychrova et al. 1989) . We first measured leucine uptake in media that contains ammonia as the nitrogen source (EMM) in the presence of 0.01 mm leucine, conditions under which only the high-affinity system is expected to transport leucine at a significant capacity (Karagiannis et al. 1999; Matsumoto et al. 2002) . As shown in Figure 5A , the uptake of rapamycintreated cells was ‫%04ف‬ of the untreated wild-type cells. Similarly, the rate of uptake by ⌬tor1 cells was ‫%04ف‬ of the wild-type cells. We also measured leucine uptake in EMM media in the presence of 2 mm leucine, conditions under which both systems are expected to import leucine, although the majority of leucine uptake can be attributed to the function of the low-affinity system (Karagiannis et al. 1999; Matsumoto et al. 2002) . In the presence of 2 mm leucine, leucine uptake by rapamycin-treated cells is reduced to ‫%05ف‬ of the untreated wild-type strain, while leucine uptake by ⌬tor1 cells is even further reduced to ‫%03ف‬ of the wild-type strain ( Figure 5B ). Importantly, uptake of radioactively labeled leucine was not reduced when cells treated with rapamycin or deleted for tor1 were grown in medium containing proline instead of ammonia ( Figure 5C ), consistent with our observation that the growth of leucine auxotrophs is not inhibited on proline plates ( Figure 3B ). Taken together, we conclude that rapamycin-treated or ⌬tor1 cells grown in ammonia-containing medium are defective in leucine uptake. In contrast, leucine uptake is not significantly reduced in rapamycin-treated or ⌬tor1 .06 and isp5 were determined by Northern blot analysis. RNA was extracted from cells grown to midlog in either EMM or EMM-Pro. Lanes 1 and 4, wild-type cells (WT); lanes 2 and 5, wild-type cells grown in the presence of 0.1 g/ml rapamycin; lanes 3 and 6, ⌬tor1 cells (⌬). (B) Changes in expression of the putative amino acid permease c869.10 were determined as in A. (C) Northern blots were quantified using the NIHimage (version 1.62) computer program. Changes in expression are presented relative to the level of expression in minimal EMM medium (considered as 100%). R, 0.1 g/ml rapamycin; Pro, EMM-Pro.
2004). tsc1
ϩ and tsc2 ϩ are the S. pombe homologs of the cells. We found that the expression of all three amino acid permeases in ammonia medium (EMM) is reduced mammalian TSC1 and TSC2, which are implicated in regulation of TOR-dependent signaling (reviewed in either by rapamycin or by deletion of tor1 ϩ (Figure 6 , A and B, lanes 1-3). The level of expression of 7G5.06 Pan et al. 2004) . Like their mammalian counterparts, the gene products of tsc1 ϩ and tsc2 ϩ physically interact, and isp5 is reduced to undetectable levels and the level of c869.10 expression is reduced fivefold, compared to indicating evolutionary conservation that extends beyond the primary amino acid sequence (Matsumoto untreated wild-type cells (changes in gene expression are normalized to standard control as depicted in Figure  et al. 2002) . Intriguingly, similar to deletion of tor1 ϩ , disruption of either tsc1 ϩ or tsc2 ϩ results in a defect in 6C). Therefore, growth inhibition or reduction in leucine uptake by rapamycin is correlated with reduction leucine uptake (Matsumoto et al. 2002; van Slegtenhorst et al. 2004) .
in expression of these three amino acid permeases. As mentioned above, the amino acid sequence of We examined the expression levels of 7G5.06, isp5, and c869.10 by Northern blot analysis in wild-type cells 7G5.06, isp5, and c869.10 shows high similarity with the Gap1 amino acid permease. Since GAP1 transcription in the absence or presence of rapamycin and in ⌬tor1 tor1 ϩ Regulates Leucine Uptake in S. pombe ⌬tor1 cells are sensitive to rapamycin in an FKBP12-dependent manner: It has previously been reported that deletion of tor1 renders cells sensitive to rapamycin (Kawai et al. 2001; ). This rapamycin sensitivity may be explained if tor1p and tor2p share a rapamycin-sensitive function . Accordingly, if tor2p is the target for rapamycin action in ⌬tor1 cells, it is expected that FKBP12-rapamycin complexes are responsible for the toxicity. We examined whether rapamycin sensitivity of ⌬tor1 is dependent on the presence of FKBP12. As seen in Figure 7A , ⌬fkh1 restored rapamycin resistance in ⌬tor1 cells, indicating that FKBP12-rapamycin complexes are responsible for the rapamycin-sensitive phenotype.
We also found that, unlike leu1-32 mutants, ⌬tor1 leu1-32 mutants are sensitive to rapamycin on rich medium as well as on minimal medium ( Figure 7A ). In addition, ⌬tor1 cells carrying no additional mutations for auxotrophy are also sensitive to rapamycin (data not shown). A simple model to explain these findings is that tor1p and tor2p share a common rapamycin-sensitive function. This function is important for regulating uptake of amino acids, as well as another, yet-unknown process ( Figure 7B ). Alternatively, only tor1p regulates leucine uptake in a rapamycin-sensitive manner, while tor1p and from the inhibition of tor1p and depends on the presence of ammonia in the medium: While the fission yeast tor1p and tor2p proteins play essential roles in growth is upregulated by poor nitrogen (Daugherty et al. 1993;  under stress or normal conditions, respectively, rapareviewed in Magasanik and Kaiser 2002), we examined mycin does not inhibit growth of wild-type S. pombe cells changes in expression in proline medium. As seen in (Weisman et al. 1997 ). Here we show that the FRB do- Figure 6 , proline medium induced expression of isp5 main of tor1p binds the FKBP12-rapamycin protein-drug by fivefold, of 7G5.06 by threefold, and of c869.10 by twofold, compared to ammonia medium. These findcomplex. Moreover, rapamycin inhibits tor1p-dependent function in leucine uptake. We show that, unlike wild ings indicate a similarity in regulation of expression among the S. cerevisiae GAP1 and 7G5.06, isp5, or type, auxotrophic cells, particularly leucine auxotrophs, are sensitive to growth in the presence of rapamycin. c869.10 by different nitrogen sources.
We also found that rapamycin treatment or deletion Both experiments of growth and direct measurements of radioactively labeled leucine uptake suggest that the of tor1 ϩ reduced the level of expression of the three amino acid permeases in proline medium ( Figure 6 , A growth inhibition of leucine auxotrophs is due to insufficient leucine uptake. Deletion of fkh1, the FKBP12 and B, lanes 4-6). However, this reduction does not result in as low a level of expression as seen in cells grown homolog in fission yeast, completely abolished rapamycin sensitivity of leucine auxotrophs. This finding in ammonia medium. Indeed, the level of expression in proline medium in the absence of tor1p or in the pressuggests that FKBP12 is not the target for rapamycin inhibition, but rather that FKBP12-rapamycin comence of rapamycin is still higher, compared to untreated wild-type cells grown in ammonia medium.
plexes are responsible for the growth-inhibition effect. Our studies of rapamycin-binding defective tor1 alleles Taken together, our findings suggest that leucineuptake deficiency in tor1 mutants or wild-type cells treated corroborate this hypothesis, as we demonstrate that mutating the conserved serine in tor1p into glutamic acid with rapamycin is correlated with reduction in expression of 7G5.06, isp5, and c869.10 in ammonia medium.
(S1834E) abolished the binding of rapamycin-FKBP12
and conferred rapamycin resistance in leucine auxoThus, while in S. cerevisiae treatment with rapamycin trophs.
leads to effects that resemble response to poor nitrogen In growth medium containing proline as the nitrogen conditions, including upregulation of GAP1 transcripsource, rapamycin does not inhibit the growth of leution, our data suggest that this is not the case in S. pombe. cine auxotrophs or reduce uptake of radioactively laOn the contrary, we show here that the transcripts of beled leucine ( Figure 3B and Figure 5 ). Thus, we sugthe three amino acid permeases, 7G5.06, isp5, or gest that in the presence of ammonia, when the expresc869.10, are induced by the poor nitrogen source prosion of ammonia-sensitive permeases is poor, further
line, yet rapamycin treatment leads to reduction in the reduction of gene expression of these permeases by expression of these permeases. Moreover, our data show rapamycin leads to growth inhibition of auxotrophic that rapamycin treatment does not mimic a condition strains. Interestingly, this effect of rapamycin on leucine equivalent to either poor or high quality of nitrogen, uptake resembles the effect of high pH (Karagiannis but rather leads to decrease in expression of 7G5.06, et al. 1999) . Like rapamycin treatment, high pH condiisp5, or c869.10 in either ammonia or proline media. tions particularly affect the growth of leucine auxoSince in ammonia medium the level of transcription trophs and can be suppressed either by replacement of is already low, further reduction in transcription may the nitrogen source in the medium from ammonia to explain the inefficient uptake of amino acid and the proline or by deletion of either wis1 ϩ or spc1 ϩ , the stressgrowth sensitivity of leucine auxotrophs. activated MAPK kinase and MAPK, respectively. High
Our results are particularly intriguing in view of repH may diminish leucine uptake by lowering the primary cent findings that link TOR and tuberous sclerosis comelectrochemical gradient across the membrane, thus causplex (TSC) signaling pathways. TSC1 and TSC2 are tuing a decrease in the uptake of secondary transport promor suppressor genes mutated in tuberous sclerosis, cesses (Karagiannis et al. 1999 ). It will be interesting to a human syndrome characterized by the widespread examine whether rapamycin treatment also affects amino development of benign tumors and severe neurological acid transport by a mechanism that involves regulation of problems. In Drosophila and mammals, it has been sugmembrane potential. Further studies are also necessary to gested that TSC1 and TSC2 work as a complex to antagodetermine the mechanism by which mutations in the nize mTOR activity (Radimerski et al. 2000 ; Gao et al. stress-activated MAPK pathway rescue leucine-uptake de-2002; Inoki et al. 2002; Tee et al. 2002) . However, more fects.
recently it has also been suggested that the TSC1-2 com-TOR signaling and nutrient uptake mechanisms: Studplex is required for PI3K/mTOR signaling, possibly by ies in S. cerevisiae and mammalian cells suggest that TOR repressing a negative feedback loop from mTOR/S6K proteins regulate cell growth partly by regulating the to the insulin receptor-1 (Harrington et al. 2004) . As activity of plasma membrane transporters, including in higher eukaryotes, the gene products of the S. pombe amino acid permeases. However, the mechanism(s) by homologs tsc1 ϩ and tsc2 ϩ work as a complex (Matsuwhich TOR proteins regulate these transporters and moto et al. 2002) . Disruption of either tsc1 ϩ or tsc2 ϩ how these contribute to cell growth regulation are far results in amino acid uptake defects and partial sterility from being clear. Studies in mammalian cells have impli- (Matsumoto et al. 2002; van Slegtenhorst et al. cated rapamycin and mTOR in transcription regulation 2004) . We have shown that tor1p is required for sexual of amino acid permeases (Peng et al. 2002) and traffickdevelopment and is a ing of the amino acid transporter 4F2hc (Edinger et positive regulator of amino acid transport (this study).
al. 2003). Our data showing that tor1p regulates amino
Moreover, tor1 or tsc1 or tsc2 mutants are defective in acid uptake in a rapamycin-sensitive manner thus supexpression of the amino acid permeases 7G5.06, isp5, port a highly evolutionarily conserved role of TOR sigand c869.10 (van Slegtenhorst et al. 2004 and Figure  naling in regulation of amino acid uptake. 6). Thus, at present, both tor1p and tsc1p-tsc2p appear In S. cerevisiae, TOR proteins regulate both specific to act as positive regulators of amino acid uptake and amino acid permeases, such as the high-affinity tryptosexual development, which does not fit a simple model phan permease Tat2p (Schmidt et al. 1998; in which tsc1p-tsc2p are negative regulators of tor1p in al. 1999), and general amino acid permeases, such as S. pombe. Given the conservation in protein structure of Gap1p. The regulation of Gap1p activity by TOR can TOR and TSC between S. pombe and human cells, it will result in apparently opposite effects. Inactivation of be interesting to determine the genetic relationship TOR by high levels of rapamycin leads to induction of between these two pathways in fission yeast. GAP1 transcription (Schmidt et al. 1998; Beck and We thank J. Heitman for S. cerevisiae two-hybrid strains and plasmids, Cardenas et al. 1999; Hardwick et al. 1999) .
P. Fantes for wis1 strains, and P. Russell for spc1 and atf1 strains.
In contrast, partial inactivation of TOR results in low We thank Shiri Finkelstein for her help in constructing two-hybrid Gap1 activity at the plasma membrane (Chen and Kai- tion of amino acid permeases, compared to S. cerevisiae.
